5-bromo-3-[6-[[1-(3-fluoro-2-pyridinyl)cyclobutyl]methylamino]pyridazin-3-yl]-2-hydroxybenzonitrile
C21H17BrFN5O — CID 136627800
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-3-[6-[[1-(3-fluoro-2-pyridinyl)cyclobutyl]methylamino]pyridazin-3-yl]-2-hydroxybenzonitrile
5-bromo-3-[6-[[1-(3-fluoro-2-pyridinyl)cyclobutyl]methylamino]pyridazin-3-yl]-2-hydroxybenzonitrile (PubChem CID 136627800) has the molecular formula C21H17BrFN5O and a molecular weight of 454.30 g/mol. Its IUPAC name is 5-bromo-3-[6-[[1-(3-fluoro-2-pyridinyl)cyclobutyl]methylamino]pyridazin-3-yl]-2-hydroxybenzonitrile.
Molecular Properties
| Compound Name | 5-bromo-3-[6-[[1-(3-fluoro-2-pyridinyl)cyclobutyl]methylamino]pyridazin-3-yl]-2-hydroxybenzonitrile |
|---|---|
| PubChem CID | 136627800 |
| Molecular Formula | C21H17BrFN5O |
| Molecular Weight | 454.30 g/mol |
| Exact Mass | 453.06 |
| IUPAC Name | 5-bromo-3-[6-[[1-(3-fluoro-2-pyridinyl)cyclobutyl]methylamino]pyridazin-3-yl]-2-hydroxybenzonitrile |
| SMILES | N#Cc1cc(Br)cc(-c2ccc(NCC3(c4ncccc4F)CCC3)nn2)c1O |
| InChI | InChI=1S/C21H17BrFN5O/c22-14-9-13(11-24)19(29)15(10-14)17-4-5-18(28-27-17)26-12-21(6-2-7-21)20-16(23)3-1-8-25-20/h1,3-5,8-10,29H,2,6-7,12H2,(H,26,28) |
| InChIKey | CXVBIVPSLOBZGP-UHFFFAOYSA-N |
| XLogP | 4.55 |
| TPSA | 94.72 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.30 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136627800 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.